Eric Dube is President, Chief Executive Officer and Director of Travere Therapeutics, Inc. (TVTX). The company reported total compensation of $8,457,151 for fiscal year 2025.
| Salary | $854,250 |
|---|---|
| Bonus | $0 |
| Stock awards | $3,314,520 |
| Option awards | $3,309,384 |
| Non-equity incentive plan | $964,125 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,872 |
| Total | $8,457,151 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Travere Therapeutics, Inc. filed April 6, 2026, accession 0001438533-26-000027.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $854,250 | $0 | $3,314,520 | $3,309,384 | $964,125 | $0 | $14,872 | $8,457,151 |
| FY2024 | President, Chief Executive Officer and Director | $822,000 | $0 | $1,607,400 | $1,895,580 | $865,200 | $0 | $14,697 | $5,204,877 |
| FY2023 | President, Chief Executive Officer and Director | $795,834 | $0 | $3,042,581 | $3,133,104 | $588,000 | $0 | $15,440 | $7,574,959 |
Totals as disclosed in each year's own compensation disclosure for Travere Therapeutics, Inc..
| Peer-group chief executive median | $10,798,796 |
|---|---|
| Difference from that median | $-2,341,645 |
| Percentile within the disclosed peer group | 44th |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Travere Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Eric Dube this page | President, Chief Executive Officer and Director | $8,457,151 |
| Jula Inrig | Chief Medical Officer | $3,041,632 |
| Peter Heerma | Chief Commercial Officer | $2,261,751 |
| William Rote | Chief Research Officer | $2,256,465 |
| Christopher Cline | Chief Financial Officer | $2,250,914 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Travere Therapeutics, Inc. compensation brief.
Eric Dube's compensation sits inside Travere Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.